Accreditation Information

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

CME

This live activity is designated for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

IPE Competencies

  • Values/Ethics for Interprofessional Practice
  • Roles/ Responsibilities
  • Interprofessional Communication
  • Teams and Teamwork

 CPE

This knowledge-based activity will award 5.5 contact hours (0.550 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Other

UK Healthcare CECentral certifies this activity for 5.5 hours of participation.

ASWB ACE

As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 5.5 clinical continuing education credits.

CNE

The maximum number of hours awarded for this Continuing Nursing Education activity is 5.5 nursing contact hours.

Objectives

Upon completion of this activity, participants will be able to:

1. Identify common diabetes foot-related complications to screen for in the clinic and cite when to triage management to podiatry. 

2. Articulate how social determinants of health can impact access to diabetes technology. 

3. Quote diagnostic criteria for MASH/MASLD and name treatment options. 

4. List ADA standards of care for bone disease, including avoidance of medications with fracture risk, timeline for bone mineral density testing, and medication treatment options. 

5. Recognize the impact of genetic variation and hormones influence glycemic control. 

6. Describe how in vivo and invitro mouse model studies to restore pancreatic beta cell function are being explored as a long-term treatment for diabetes 

7. Relate how brain health impacts metabolic diseases like diabetes through hepatokine-based energy regulation. 

Target Audience

Physicians, Pharmacists, Nurses, Social Workers, Public Health Professionals, Dieticians, CDCES

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by the University of Kentucky are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.